Sanofi to launch HIB shot in Japan

Sanofi Pasteur says it's poised to enter the Japanese market with its ActHIB vaccine that targets Haemophilius influenza type b; the shot will be marketed there by Daiichi-Sankyo and will be available beginning next month. Report